These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23390861)

  • 41. Comparison between abnormal cytology, colposcopy and histopathology during pregnancy.
    Lundvall L
    Acta Obstet Gynecol Scand; 1989; 68(5):447-52. PubMed ID: 2520791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of Pap test abnormalities within 3 years of a normal Pap test--United States, 1991-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(44):1001-3. PubMed ID: 11097139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer and pregnancy: recent developments.
    Ward RM; Bristow RE
    Curr Opin Obstet Gynecol; 2002 Dec; 14(6):613-7. PubMed ID: 12441701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. See-and-treat strategy for diagnosis and management of cervical squamous intraepithelial lesions.
    Cárdenas-Turanzas M; Follen M; Benedet JL; Cantor SB
    Lancet Oncol; 2005 Jan; 6(1):43-50. PubMed ID: 15629275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
    Adam Y; McIntyre JA; De Bruyn G
    S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings.
    Sawaya GF; McConnell KJ; Kulasingam SL; Lawson HW; Kerlikowske K; Melnikow J; Lee NC; Gildengorin G; Myers ER; Washington AE
    N Engl J Med; 2003 Oct; 349(16):1501-9. PubMed ID: 14561792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are Women With Uterine Fibroids at Increased Risk for Adverse Pregnancy Outcome?
    Ezzedine D; Norwitz ER
    Clin Obstet Gynecol; 2016 Mar; 59(1):119-27. PubMed ID: 26670833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Underutilization of the Papanicolaou smear in human immunodeficiency virus-positive women.
    Strigle SM; Walts AE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):206. PubMed ID: 7749800
    [No Abstract]   [Full Text] [Related]  

  • 49. Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia.
    Bjørge T; Skare GB; Bjørge L; Tropé A; Lönnberg S
    Obstet Gynecol; 2016 Dec; 128(6):1265-1273. PubMed ID: 27824756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adolescents with abnormal cervical cytology.
    Schydlower M; Greeenberg H; Patterson PH
    Clin Pediatr (Phila); 1981 Nov; 20(11):723-6. PubMed ID: 7297012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical cancer screening in pregnancy.
    Stonehocker J
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):269-82. PubMed ID: 23732031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
    Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of cervical cancer. Guidelines].
    Collège National des Gynécologues et Obstétriciens Français
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S167-72. PubMed ID: 18409213
    [No Abstract]   [Full Text] [Related]  

  • 55. [Management of CIN1].
    Rouzier R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S114-20. PubMed ID: 18191500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up.
    Heard I; Bergeron C; Jeannel D; Henrion R; Kazatchkine MD
    Obstet Gynecol; 1995 Nov; 86(5):749-53. PubMed ID: 7566842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force.
    Vesco KK; Whitlock EP; Eder M; Burda BU; Senger CA; Lutz K
    Ann Intern Med; 2011 Nov; 155(10):698-705, W216. PubMed ID: 22006929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-grade cervical squamous intraepithelial lesion during pregnancy.
    Murta EF; de Souza FH; de Souza MA; Adad SJ
    Tumori; 2002; 88(3):246-50. PubMed ID: 12195765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
    Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD
    J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
    Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
    Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.